These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31107862)

  • 61. Two Distinct Cases of Adult-onset Kawasaki Disease.
    Onoki T; Metoki T; Iwasawa S; Kawano K; Kimura M; Kure S; Ota C
    Intern Med; 2022 Dec; 61(23):3525-3529. PubMed ID: 35466164
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G; Jianming L; Suqian T; Dong Q; Shuang L; Jin Z
    BMC Pediatr; 2022 Jan; 22(1):29. PubMed ID: 34996405
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
    Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
    Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
    Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
    Wang J; Chen H; Shi H; Zhang X; Shao Y; Hang B; Xu Z; Rong X; Chu M; Qiu H
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):48. PubMed ID: 32527316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
    Platt B; Belarski E; Manaloor J; Ofner S; Carroll AE; John CC; Wood JB
    JAMA Netw Open; 2020 Jan; 3(1):e1918565. PubMed ID: 31899532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D; Moraes YC; Purvis C; Pursell M; Morillas MM; Kahn R; Mossberg M; Kucera F; Tulloh R; Standing JF; Swallow V; McCormack R; Herberg J; Levin M; Wan M; Klein N; Connon R; Walker AS; Brogan P
    Trials; 2023 Jan; 24(1):60. PubMed ID: 36703139
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort.
    Grasa CD; Fernández-Cooke E; Domínguez-Rodríguez S; Aracil-Santos J; Barrios Tascon A; Sánchez-Manubens J; Mercader B; Antón J; Nuñez E; Villalobos E; Bustillo M; Camacho M; Oltra Benavent M; Giralt G; Bello Naranjo AM; Rocandio B; Calvo C;
    Clin Rheumatol; 2022 Dec; 41(12):3759-3768. PubMed ID: 35939163
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
    Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children].
    Deng YC; Wang X; Tang XC; Huang CZ; Yang J; Mo LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):927-31. PubMed ID: 26412172
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome.
    Wilder MS; Palinkas LA; Kao AS; Bastian JF; Turner CL; Burns JC
    Pediatr Infect Dis J; 2007 Mar; 26(3):256-60. PubMed ID: 17484225
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
    Takekoshi N; Kitano N; Takeuchi T; Suenaga T; Kakimoto N; Suzuki T; Kada TT; Shibuta S; Tachibana S; Murayama Y; Yamaga H; Suzuki H
    JAMA Netw Open; 2022 Jun; 5(6):e2216642. PubMed ID: 35696166
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    Pediatr Infect Dis J; 2023 Jul; 42(7):608-613. PubMed ID: 37053581
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 76. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
    Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
    Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epidemiology of Kawasaki Disease in South Korea: A Nationwide Survey 2015-2017.
    Kim GB; Eun LY; Han JW; Kim SH; Yoon KL; Han MY; Yu JJ; Choi JW; Rhim JW
    Pediatr Infect Dis J; 2020 Nov; 39(11):1012-1016. PubMed ID: 33075217
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analysis of risk factors and prospective evaluation of cardiovascular complications of Kawasaki disease in children: a single centre study.
    Berdej-Szczot E; Firek-Pędras M; Szydłowski L; Krzystolik-Ładzińska J; Klimek K; Małecka-Tendera E
    Kardiol Pol; 2013; 71(12):1279-86. PubMed ID: 23990228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.